Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Evotec is a drug discovery alliance. It is focused on rapidly developing innovative drugs and other products with leading pharmaceutical and biotechnology companies. Its partners include Bayer, Boehringer Ingelheim, Genentech and Janssen Pharmaceuticals. In addition, Evotec has product candidates both in clinical and pre-clinical development.
Gilde obtained listed Evotec shares (Frankfurt Stock Exchange: EVT) in 2007 after Evotec acquired the French company Neuro3D for its clinical program in schizophrenia.
More Evotec news
Venture&Growth
Mobia Medical
Mobia Medical is a U.S.-based, growth-stage company commercializing the Vivistim Paired VNS System, an implantable neurostimulation therapy that improves outcomes for chronic ischemic stroke survivors with upper limb motor deficits. Vivistim Paired VNS System is an implantable neurostimulation therapy that
Venture&Growth
Proverum
Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity College Dublin, developing novel treatment solutions for patients with symptomatic benign prostatic hyperplasia (BPH). BPH is a highly prevalent condition impacting an estimated 14 million
Venture&Growth
Shoulder Innovations
Shoulder Innovations is a US-based medical device company that is commercializing a novel shoulder arthroplasty portfolio paired with an AI-enabled surgical planning software. The portfolio is anchored by Shoulder Innovations’ proprietary InSetTM glenoid fixing technology to solve the problem of
